Notice of NIDA's Participation in PAR-17-257 "PsychENCODE: Non-coding Functional Elements in the Human Brain and their Role in the Development of Psychiatric Disorders (U01)"

Notice Number: NOT-DA-17-052

Key Dates
Release Date: August 7, 2017

Related Announcements
PAR-17-257

Issued by
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute on Drug Abuse (NIDA) will participate, effective immediately, in PAR-17-257 " PsychENCODE: Non-coding Functional Elements in the Human Brain and their Role in the Development of Psychiatric Disorders (U01)". NIDA is especially interested supporting projects focused on regions of the brain that are important for substance abuse disorders and/or related cormorbid conditions. 
The following portions of the FOA are modified to reflect NIDA's particpation:

Part 1. Overview Information 
Components of Participating Organizations

National Institute of Mental Health (NIMH)
National Institute on Drug Abuse (NIDA)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.242,   93.279

The following contacts have been added to the FOA.
Part 2. Section VII. Agency Contacts
Scientific/Research Contact(s)
Amy C. Lossie, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-6092
Email: amy.lossie@nih.gov

Financial/Grants Management Contact(s)
Cheryl Nathaniel
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-6703
Email: nathanic@nida.nih.gov

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Amy C. Lossie, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-6092
Email: amy.lossie@nih.gov